Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Jun;73(11):1428–1430. doi: 10.1038/bjc.1996.271

A pilot study on risk factors and p53 gene expression in colorectal cancer.

M Fredrikson 1, O Axelson 1, X F Sun 1, G Arbman 1, E Nilsson 1, B Nordenskjöld 1, R Sjödahl 1, P Söderkvist 1
PMCID: PMC2074496  PMID: 8645592

Abstract

Of 311 colorectal cancers diagnosed in 1984-86 in the county of Ostergotland, Sweden, 179 were included in a case-control study, and, of these, 70 were investigated using immunohistochemical staining for p53 gene mutations. Alcohol use as well as medication with hydralazine-containing antihypertensive drugs, but not heredity were associated with p53 staining. The study is offered to illustrate the possible value of investigating molecularly defined tumour subtypes in relation to specific risk factors.

Full text

PDF
1429

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaltonen L. A., Peltomäki P., Leach F. S., Sistonen P., Pylkkänen L., Mecklin J. P., Järvinen H., Powell S. M., Jen J., Hamilton S. R. Clues to the pathogenesis of familial colorectal cancer. Science. 1993 May 7;260(5109):812–816. doi: 10.1126/science.8484121. [DOI] [PubMed] [Google Scholar]
  2. Arbman G., Axelson O., Fredriksson M., Nilsson E., Sjödahl R. Do occupational factors influence the risk of colon and rectal cancer in different ways? Cancer. 1993 Nov 1;72(9):2543–2549. doi: 10.1002/1097-0142(19931101)72:9<2543::aid-cncr2820720906>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  3. Axelson O., Flodin U., Hardell L. A comment on the reference series with regard to multiple exposure evaluations in a case-referent study. Scand J Work Environ Health. 1982;8 (Suppl 1):15–19. [PubMed] [Google Scholar]
  4. Axelson O. Some recent developments in occupational epidemiology. Scand J Work Environ Health. 1994;20(Spec No):9–18. [PubMed] [Google Scholar]
  5. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  6. Fredriksson M., Bengtsson N. O., Hardell L., Axelson O. Colon cancer, physical activity, and occupational exposures. A case-control study. Cancer. 1989 May 1;63(9):1838–1842. doi: 10.1002/1097-0142(19900501)63:9<1838::aid-cncr2820630930>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  7. Greenblatt M. S., Bennett W. P., Hollstein M., Harris C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994 Sep 15;54(18):4855–4878. [PubMed] [Google Scholar]
  8. Ionov Y., Peinado M. A., Malkhosyan S., Shibata D., Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 1993 Jun 10;363(6429):558–561. doi: 10.1038/363558a0. [DOI] [PubMed] [Google Scholar]
  9. Ishioka C., Frebourg T., Yan Y. X., Vidal M., Friend S. H., Schmidt S., Iggo R. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet. 1993 Oct;5(2):124–129. doi: 10.1038/ng1093-124. [DOI] [PubMed] [Google Scholar]
  10. Kaufman D. W., Kelly J. P., Rosenberg L., Stolley P. D., Warshauer M. E., Shapiro S. Hydralazine use in relation to cancers of the lung, colon, and rectum. Eur J Clin Pharmacol. 1989;36(3):259–264. doi: 10.1007/BF00558157. [DOI] [PubMed] [Google Scholar]
  11. Levine A. J., Momand J., Finlay C. A. The p53 tumour suppressor gene. Nature. 1991 Jun 6;351(6326):453–456. doi: 10.1038/351453a0. [DOI] [PubMed] [Google Scholar]
  12. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., Hedge P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science. 1991 Aug 9;253(5020):665–669. doi: 10.1126/science.1651563. [DOI] [PubMed] [Google Scholar]
  13. Potter J. D., Slattery M. L., Bostick R. M., Gapstur S. M. Colon cancer: a review of the epidemiology. Epidemiol Rev. 1993;15(2):499–545. doi: 10.1093/oxfordjournals.epirev.a036132. [DOI] [PubMed] [Google Scholar]
  14. Rodrigues N. R., Rowan A., Smith M. E., Kerr I. B., Bodmer W. F., Gannon J. V., Lane D. P. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7555–7559. doi: 10.1073/pnas.87.19.7555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stevens R. G., Jones D. Y., Micozzi M. S., Taylor P. R. Body iron stores and the risk of cancer. N Engl J Med. 1988 Oct 20;319(16):1047–1052. doi: 10.1056/NEJM198810203191603. [DOI] [PubMed] [Google Scholar]
  16. Sun X. F., Carstensen J. M., Zhang H., Stål O., Wingren S., Hatschek T., Nordenskjöld B. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet. 1992 Dec 5;340(8832):1369–1373. doi: 10.1016/0140-6736(92)92558-w. [DOI] [PubMed] [Google Scholar]
  17. Toth B. Tumorigenic effect of 1-hydrazinophthalazine hydrochloride in mice. J Natl Cancer Inst. 1978 Nov;61(5):1363–1365. doi: 10.1093/jnci/61.5.1363. [DOI] [PubMed] [Google Scholar]
  18. Vena J. E., Graham S., Zielezny M., Swanson M. K., Barnes R. E., Nolan J. Lifetime occupational exercise and colon cancer. Am J Epidemiol. 1985 Sep;122(3):357–365. doi: 10.1093/oxfordjournals.aje.a114116. [DOI] [PubMed] [Google Scholar]
  19. Yamamoto K., Kawanishi S. Free radical production and site-specific DNA damage induced by hydralazine in the presence of metal ions or peroxidase/hydrogen peroxide. 1991 Mar 15-Apr 1Biochem Pharmacol. 41(6-7):905–914. doi: 10.1016/0006-2952(91)90195-b. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES